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*(J E Nicoletti-Carvalho and T C Arau´jo Nogueira contributed equally to this work)AbstractUnfolded protein response (UPR)-mediated pancreatic b-cell
death has been described as a common mechanism by which
palmitate (PA) and pro-inflammatory cytokines contribute to the
development of diabetes. There are evidences that interleukin 6
(IL6) has a protective action against b-cell death induced
by pro-inflammatory cytokines; the effects of IL6 on PA-induced
apoptosis have not been investigated yet. In the present study,
we have demonstrated that PA selectively disrupts IL6-induced
RAC-alpha serine/threonine-protein kinase (AKT) activation
without interfering with signal transducer and activator of
transcription 3 phosphorylation in RINm5F cells. The inability
of IL6 to activate AKT in the presence of PA correlated with an
inefficient protection against PA-induced apoptosis. In contrast
to PA, IL6 efficiently reduced apoptosis induced by pro-
inflammatory cytokines. In addition, we have demonstratedJournal of Endocrinology (2010) 206, 183–193
0022–0795/10/0206–183 q 2010 Society for Endocrinology Printed in Greatthat IL6 is unable to overcomePA-stimulatedUPR, as assessed by
activating transcription factor 4 (ATF4) andC/EBP homologous
protein (CHOP) expression, X-box binding protein-1 gene
mRNA splicing, and pancreatic eukaryotic initiation factor-2a
kinase phosphorylation, whereas no significant induction of
UPR by pro-inflammatory cytokines was detected. This
unconditional stimulation of UPR and apoptosis by PA was
accompanied by the stimulation of CHOP and tribble3
(TRIB3) expression, irrespective of the presence of IL6. These
findings suggest that IL6 is unable to protect pancreatic b-cells
from PA-induced apoptosis because it does not repress UPR
activation. In this way, CHOP and ATF4 might mediate
PA-induced TRIB3 expression and, by extension, the suppres-
sion of IL6 activation of pro-survival kinase AKT.
Journal of Endocrinology (2010) 206, 183–193Introduction
Obesity and insulin resistance are tightly associated with the
onset of type 2 diabetes mellitus (T2DM), possibly due to
increased circulating levels of glucose and free fatty acids
(FFAs), which are known to induce b-cell apoptosis, a
phenomenon known as glucolipotoxicity (Donath et al.
2005). However, the precise relevance and the mechanisms by
which FFAs trigger b-cell death are still unclear. In contrast to
T2DM, type 1 diabetes mellitus (T1DM) is well defined by
pancreatic b-cell injury due to the action of pro-inflam-
matory cytokines, such as interleukin-1b (IL-1b), interferon-
g (IFN-g), and tumour necrosis factor-a (TNF-a), which are
released by infiltrated immune cells (Cnop et al. 2005).
Several recent studies have described that both pro-
inflammatory cytokines and FFAs induce an imbalancebetween endoplasmic reticulum (ER) folding demand and
capacity in the b-cells, the so-called ER stress. The cellular
consequence of the ER stress is the unfolded protein response
(UPR) activation. The initial goal of UPR is to accomplish
ER folding rate to the increased demand. However, if the
stress persists, the termination phase of UPR targets apoptosis
(Ron & Walter 2007). UPR-activated apoptosis occurs by a
yet-unrevealed mechanism, but the increase in c-Jun
N-terminal kinase activation and C/EBP homologous
protein (CHOP) expression is likely to be the essential step
(Kharroubi et al. 2004, Akerfeldt et al. 2008).
Great attention is being paid to IL6 produced by
adipocytes due to its possible involvement in the onset of
T2DM (Herder et al. 2006). IL6 production is directly
proportional to adipose tissue mass, which generates more
than 30% of its serum levels (Mohamed-Ali et al. 1997).DOI: 10.1677/JOE-09-0356
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(Glund & Krook 2008), IL6 has been shown to play a
complex role in pancreatic b-cell death in diabetes. IL6 was
described to counteract pancreatic b-cell apoptosis induced
by pro-inflammatory cytokines (Park et al. 2003, Choi et al.
2004), and to increase cell death in primary islets treated with
FFAs (Ellingsgaard et al. 2008). Paradoxically, it was observed
that the incidence of T1DM in non-obese diabetic (NOD)
mice decreased when the mice were crossed with transgenic
mice overexpressing IL6 (DiCosmo et al. 1994).
In spite of the evident increased levels of IL6 in obese and
insulin-resistant patients and the diabetogenic properties of
this cytokine, no data are available regarding the ability of IL6
to modulate FFA-induced ER stress in pancreatic b-cells. In
order to assess this issue, we investigated whether IL6
modulates palmitate (PA)-induced b-cell apoptosis by
focusing on IL6 intracellular signaling pathways and the
main branches of UPR.Materials and Methods
RINm5F cell culture and incubation
The rat insulinoma cell line RINm5F was cultured in RPMI-
1640 medium (11.1 mM glucose and 10% FBS) as described
previously (Anheˆ et al. 2007). For the time-course and dose–
response experiments, the cells were incubated for 30 min at
37 8C with Krebs-bicarbonate buffer (KBB) containing
0.3 mM glucose prior to the incubation with rat IL6
(Sigma). For the time-course and dose–response experiments,
incubation with IL6 was carried out using KBB at different
intervals and at several concentrations (indicated in the
figures) respectively. PA (Sigma) treatment at prolonged
intervals was carried out in a serum-free medium containing
1% of fatty acid-free BSA. Cells were pre-treated with IL6
(100 ng/ml) for 24 h, and then the medium was replaced with
a fresh medium containing IL6 alone or in combination with
PA, followed by incubation for an additional 12 h. PA was
dissolved in 95% ethanol to a concentration of 100 mM, and
heated to 60 8C for 30 min. Alcoholic PA solution was added
to the culture medium to yield a final concentration of
250 mM (boundCunbound). Ethanol at a final concentration
of 0.25% (v/v) was added to all the cultures in which PA
was absent.
Treatment with pro-inflammatory cytokine mixture (CM)
was carried out in RPMI-1640 medium containing 11.1 mM
glucose and 10% FBS. Incubation that was carried out using
CM lasted for 24 h, and was preceded by a 24 h incubation
with IL6. Thus, in these experiments, the total interval during
which the cells were exposed to IL6 was 48 h, and during the
last 24 h of this time period, the cells were grown in the
presence or absence of CM. CM was prepared using a
combination of IL1b (60 U/ml, 4.4 ng/ml), IFN-g
(14 U/ml, 10.3 ng/ml), and TNF-a (185 U/ml, 4.4 ng/ml;
Souza et al. 2008).Journal of Endocrinology (2010) 206, 183–193Transfection of RINm5F cells with small interfering RNA
(siRNA) targeted at CHOP (sc-156118, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or scrambled control
siRNA (sc-37007, Santa Cruz Biotechnology) was performed
as described previously (Anheˆ et al. 2010). Briefly, the cells
were washed twice with a serum-free medium (Opti-MEM,
Invitrogen), and were then incubated with 1 ml of the same
medium containing the siRNA (final concentration of
80 nM) previously mixed with 2 ml Lipofectamine 2000
(Invitrogen), or Lipofectamine only (CTL). After 7 h, 1 ml of
RPMI medium containing 20% FBS and 22.2 mM glucose
was added to the culture containing siRNAs and Lipofecta-
mine, and the cells were incubated for an additional 12 h (final
concentrations of FBS and glucose were 10% and 11.1 mM
respectively). Thereafter, the cells were allowed to grow for
60 h in RPMI medium (11.1 mM glucose and 10% FBS) that
was replaced every 24 h. After this period, the cells were
treated with PA for 12 h as described above.Pancreatic islet isolation and culture
Islets were isolated by collagenase digestion as described
previously (Bordin et al. 1995). All the experiments involving
animals were performed in accordance with the guidelines of
the Brazilian College for Animal Experimentation (COBEA).
After isolation, groups of ca. 400 islets were extensively and
carefully washed with KBB containing antibiotics, and were
cultured for 24 h. In order to induce apoptosis, pancreatic
islets were cultured with PA in RPMI-1640 medium
containing 11.1 mM glucose, 10% FBS, and 2% of fatty
acid-free BSA as described previously (Shimabukuro et al.
1998). Total (boundCunbound) PA concentration used was
1 mM, and IL6 concentration was 100 ng/ml. Treatments
with PA and/or IL6 were performed for 24 h. After culture,
groups of w250 islets grown under each condition were
processed for protein extraction and western blotting or for
the detection of DNA fragmentation. For DNA fragmenta-
tion, groups of 50 islets were dissociated by re-suspension in
Ca2C-free KBB containing EDTA.Caspase-3 activity
Cells were seeded in six-well plates (5!105/well), and treated
as described in the figure legends. Afterwards, the cells were
centrifuged at 1000 g for 15 min at 4 8C, and 200 ml of a lysis
buffer containing 10% sucrose, 0.1% CHAPS, 100 mM
HEPES, pH 7.4, 10 mg/ml leupeptin, 10 mg/ml aprotinin,
2 mM phenylmethylsulphonyl fluoride (PMSF), and 10 mM
dithiothreitol (DTT) were added to the pellet. The cells were
incubated for 30 min at 4 8C and centrifuged at 12 000 g for
30 min at 4 8C. The supernatant was collected, and the protein
content was determined by the Bradford method. Caspase-3
protease activity was determined by incubating the lysate
(20 mg of total protein) with 50 mM fluorogenic substrate
Ac-DEVD-AMC (Sigma) in a buffer containing 10% sucrose,
100 mM HEPES, pH 7.4, 10 mg/ml leupeptin, 10 mg/mlwww.endocrinology-journals.org
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activity was assessed by measuring the fluorescence of Asp-7-
amino-4-trifluoromethyl coumarin released at 30 min during
the 5-min intervals using a spectrofluorometer (Molecular
Devices Spectra MAX Gemini XS, Sunnyvale, CA, USA).Determination of membrane integrity and DNA fragmentation
Cells were seeded in six-well plates (5!105/well), and were
treated as described in the figure legends. Afterwards, the cells
were harvested with trypsin, washed, and suspended in PBS.
Cell suspensions were divided into two aliquots, and were
used to determine DNA fragmentation and membrane
integrity. Both the methodologies were based on propidium
iodide (PI) staining and fluorescence, which was measured
using a flow cytometer. First, 50 ml of isotonic solution
containing PI (50 mg/ml in PBS) were used to homogenize
one pelleted aliquot from each sample, and were immediately
analyzed using a FACSCalibur flow cytometer (Becton
Dickinson, San Juan, PR, USA). PI is highly hydrosoluble
and usually does not significantly diffuse into the cell.
However, when membrane integrity is disrupted, it does
occur, making the cell emit fluorescence when excited by the
laser. Fluorescence was measured using the FL2 channel
(orange-red fluorescence; 585/42 nm). Ten thousand events
were analyzed per sample using the CellQuest software
(Becton Dickinson). DNA fragmentation was measured by
staining the second aliquot of the cell suspension obtained
from each sample with a PI solution according to the method
described previously (Verlengia et al. 2003). In this case, the
cells were incubated for 1 h at room temperature (RT) with a
PI solution containing 0.1% Triton X-100 (50 mg/ml PI,
0.1% sodium citrate, and 0.1% Triton X-100). The presence
of the detergent in the solution makes the cell membrane
permeable to PI, allowing it to be incorporated into cellular
DNA. Fluorescence was measured and analyzed using the
CellQuest software, and low fluorescence was emitted by
fragmented DNA, while intact haploid and diploid DNAs
emitted characteristic two-peaked high-intensity fluorescence.RINm5F cell proliferation
Cell proliferation was assessed by measuring bromodeoxy-
uridine (BrdU) incorporation into DNA using a commercial
kit (Millipore, Billerica, MA, USA; Cat. no. 2750). Briefly,
4!104 cells were seeded in a 96-well plate, and were allowed
to attach to the wells containing the growth medium
overnight. On the next day, the medium was replaced with
low serum medium (0.1% FBS), in which each treatment was
carried out. Cytokine mixture, PA and IL6 concentrations
and incubation periods were exactly the same as those used for
apoptosis assays. BrdU stock solution (provided with the kit)
was diluted 500! and added to the medium 4 h before the
end of the treatments. One well maintained under each
condition was kept without BrdU to be used as the
background (BG). After incubation, the medium waswww.endocrinology-journals.orgremoved, and a fixing solution was added to the adhered
cells for 30 min at RT. The fixing solution was removed, and
the cells were washed three times with 1! washing solution.
Next, the cells were incubated for 1 h at RTwith anti-BrdU
antibody diluted 200! in antibody diluents. Cells were
washed three times and were then incubated with goat anti-
mouse IgG antibody conjugated with peroxidase for 30 min
at RT. Afterwards, the cells were washed and incubated with
3,3 0,5,5 0-tetramethylbenzidine sulfate (TMB) peroxidase
substrate for 30 min at RT in the dark, and then a stop
solution was added. Using a spectrophotometer, 450-nm light
absorbance was acquired. Blanks (TMB peroxidase substrate
plus the stop solution) were discounted from all the readings,
and the respective BG absorbance was discounted from each
condition.RNA extraction and RT-PCR
Cells were harvested in TRIzol, and were processed for total
RNA extraction and cDNA synthesis, which were performed
using conventional (GoTaq DNA Polymerase, Promega) or
real-time (SYBR Green master mix, Applied Biosystems,
Foster City, CA, USA) PCR. The sequences of the primers
and amplification conditions were as follows: B-cell
CLL/lymphoma (Bcl2; NM_016993) sense 5 0-GCAGA-
GATGTCCAGTCAGC-3 0 and antisense 5 0-CCCACCGA-
ACTCAAAGAAGG-3 0, 128 bp, 55 8C; Bcl2 associated X
protein (Bax; NM_017059) sense 5 0-GGAGATGAACTG-
GACAATAATATGG-3 0 and antisense 5 0-GCAAAGTA-
GAAGAGGGCAACC-30, 151 bp, 53 8C; b2-microglobulin
(b2M; NM_012512) sense 50-CTCAGTTCCACCCACCT-
CAG-3 0 and antisense 5 0-GCAAGCATATACATCGG-
TCTC-30, 157 bp, 56 8C; succinate dehydrogenase subunit
A (Sdha; NM_130428) sense 50-CGGAAGCACGGAAGG-
AGTC-3 0 and antisense 5 0-CAGTAGGAACGGATAG-
CAGGAG-3 0, 249 bp, 56 8C. Relative expression levels
were analyzed using the 2(KDDC(T)) method (Livak &
Schmittgen 2001) with b2m and Sdha as the internal controls.
Conventional RT-PCR was performed for the analysis of
X-box binding protein gene (Xbp1) splicing as described
previously (Kharroubi et al. 2004). Briefly, PCR products
were incubated with the PstI restriction enzyme for 5 h at
37 8C, followed by separation on a 2% EtBr agarose gel.
Primer sequences and amplification conditions were as
follows: Xbp1 (NM_001004210) sense 5 0-AAACAGAG-
TAGCAGCGCAGACTGC-3 0 and antisense 50-GGATC-
TCTAAAACTAGAGGCTTGGTG-3 0, 600 bp, 52 8C.Western blotting
Cells were harvested in a lysis buffer and homogenized by
sonication. After centrifugation, equal amounts of protein
were resolved by SDS-PAGE, and transferred onto nitro-
cellulose membranes. Detection using specific antibodies,
HRP-conjugated secondary antibodies, and luminol solution
was performed as described previously (Anheˆ et al. 2006).Journal of Endocrinology (2010) 206, 183–193
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transcription 3 (STAT3) (sc483), anti-phospho-STAT3 Tyr
(sc8059), anti-CHOP (sc575 and sc793), anti-phospho-
AKT1/2/3 Ser (sc33437), anti-tribble3 (TRIB3) (sc34212),
and anti-activating transcription factor 4 (ATF4) (sc200)
antibodies were obtained from Santa Cruz Technology.
Anti-BAX (B3428) and anti-b-actin (A5316) antibodies
were obtained from Sigma; anti-AKT1 (05-796) was obtained
from Upstate Biotechnology (Waltham, MA, USA); and anti-
phospho-pancreatic eukaryotic initiation factor-2a kinase
(PERK) Thr980 (3179) and anti-immunoglobulin heavy
chain-binding protein (BiP) (3183) antibodies were obtained
from Cell Signaling Technology (Beverly, MA, USA).
Densitometry was performed using the Scion Image software
(Scion Corporation, Frederick, MD).*
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Results are presented as meansGS.E.M. Comparisons were
performed using one-way ANOVA with the Tukey–Kramer
post-test (InStat – GraphPad Software, Inc., San Diego, CA,
USA). The level of significance was set at P!0.05.
CTL IL6 CM IL6+CM CTL IL6 CM IL6+CM
Figure 1 IL6-induced AKT and STAT3 phosphorylation and
protection against apoptosis elicited by pro-inflammatory cyto-
kines in RINm5F cells. RINm5F cells were stimulated with IL6
(100 ng/ml) for 1.5, 5, 15, 30, 60, and 90 min (A). Cells were also
incubated for 30 min with IL6 at the final concentrations of 10, 25,
50, 75, and 100 ng/ml (B). Afterwards, the cells were processed for
protein extraction and detection of STAT3, pSTAT3(Tyr), AKT, and
pAKT(Ser) (nZ3). RINm5F cells were treated with IL6 (100 ng/ml) in
combination with or without a mixture of IL1b (4.4 ng/ml), IFN-g
(10.3 ng/ml), and TNF-a (4.4 ng/ml; cytokine mixture, CM).
Untreated cells are designated as CTL cells. After 24 h, cellular
DNA fragmentation (C), caspase-3 activity (D), cell membrane
integrity (E), and cell proliferation rate (F) were analyzed (see
Materials and Methods). Results are shown as meanGS.E.M.
*P!0.05, **P!0.01 and ***P!0.001 versus CTL, #P!0.05 and
&P!0.001 versus CM (nZ3–6).Results
IL6 modulation of STAT3 and AKT phosphorylation and
pro-inflammatory cytokine-induced apoptosis and suppression
of proliferation
We have demonstrated the activation of proteins downstream
of the IL6 receptor, namely STAT3 and protein kinase
B/AKT. The phosphorylation of both STAT3-tyrosine and AKT-
serine peaked at 15 min after incubation with IL6 (Fig. 1A).
The concentration of IL6 used in the further experiments was
also assessed. IL6 at 100 ng/ml produced a significant increase
in the phosphorylation of both STAT3 and AKT (Fig. 1B).
Figure 1C shows that CM-treated cells displayed higher DNA
fragmentation (2.3-fold of the CTL values) which was
abolished by pre-treatment with IL6. These changes
paralleled the modulation of caspase-3 activity. Figure 1D
shows that CM increased caspase-3 activity (10.8-fold of the
CTL values) and IL6 diminished CM-induced caspase-3
activation (0.36-fold compared with the CM-treated cells).
Cell viability was not significantly changed by CM treatment
(Fig. 1E). In contrast, Fig. 1F shows that both IL6 and CM
decreased cell proliferation (to 0.85- and to 0.56-fold of the
CTL values respectively). Additionally, the combination of
CM and IL6 prompted a more pronounced reduction in cell
proliferation (0.03-fold of the CTL values).Effects of IL6 on PA-induced cell death and proliferation, and
STAT3 and AKT phosphorylation
The percentage of RINm5F cells with fragmented DNA
increased approximately fourfold on PA treatment (Fig. 2A).
Concordantly, PA treatment of RINm5F cells increasedJournal of Endocrinology (2010) 206, 183–193caspase-3 activity w30-fold when compared with the CTL
cells (Fig. 2B). IL6 treatment did not change basal or
PA-induced DNA fragmentation and caspase-3 activation. PA
treatment reduced cell viability to w0.8-fold of the CTL
values, and this effect was not modulated by IL6 treatment
(Fig. 2C). Figure 2D shows that both IL6 and PA decreased
cell proliferation (to 0.85- and to 0.37-fold of the CTL values
respectively). The combination of IL6 and PA did not
promote a further reduction in cell proliferation.
On the other hand, IL6 signaling was differentially
regulated by PA. The phosphorylation of both STAT3 and
AKT was increased by IL6 (2.1-fold of the CTL values for
both STAT3 and AKT), but only IL6-induced AKT
phosphorylation was suppressed by PA (Fig. 3).Regulation of pro- and anti-apoptotic proteins by IL6 and PA
IL6 by itself increased the expression of the anti-apoptotic
Bcl2 mRNA (2.7-fold of the CTL values). Bcl2 mRNAwww.endocrinology-journals.org
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Figure 2 Modulation of apoptosis and cellular viability by palmitate
and IL6. RINm5F cells were treated with IL6 (100 ng/ml for 36 h).
Palmitate (PA; 250 mM) was added during the last 12 h of the 36-h
period. CTL cells were treated with a vehicle. Next, DNA
fragmentation (A) and cell membrane integrity (C) were analyzed by
propidium iodide fluorescence assessed using a flow cytometer.
Caspase-3 activity (B) was evaluated by spectrofluorometry, and the
proliferation rate (D) was evaluated based on BrdU incorporation.
Results are shown as meanGS.E.M. *P!0.05, and ***P!0.001
versus CTL and IL6 (nZ6–15).
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with IL6 (by 0.5- and 0.4-fold of the CTL values respectively;
Fig. 4A). The absolute levels of BCL2 protein were not
altered by either IL6 or PA (Fig. 4B). The levels of the pro-
apoptotic BCL2-associated X protein (Bax) mRNA were
downregulated by IL6 (0.3-fold of the CTL values),
and upregulated by PA alone or in combination with IL6
(by 2.2- and 1.8-fold of the CTL values respectively;
Fig. 4C). IL6 decreased BAX protein content (0.6-fold of
the CTL values), but the presence of PA abolished this effect
(Fig. 4D). IL6 increased Bcl2/Bax mRNA ratio (10-fold of
the CTL values), whereas PA decreased it (0.3-fold of the
CTL values). In addition, Bcl2/Bax mRNA ratio remained
reduced when IL6 was combined with PA (Fig. 4E). BCL2/
BAX protein ratio was increased by IL6 alone (1.8-fold of the
CTL values), but this effect was abolished when PAwas added
to the medium (Fig. 4F).
0·0
CTL IL6 PA IL6+PA
Figure 3 Modulation of STAT3 and AKT phosphorylation by
palmitate and IL6. RINm5F cells were treated with IL6 (100 ng/ml
for 36 h). Palmitate (PA; 250 mM) was added during the last 12 h of
the 36-h period. CTL cells were treated with a vehicle. Protein was
extracted, resolved by SDS-PAGE and transferred onto nitrocellu-
lose membranes that were probed for the detection of tyrosine-
phosphorylated STAT3, serine-phosphorylated AKT, and
b-actin (loading control) (A), and the intensity of the bands was
analyzed by densitometry using different sets of experiments (B) and
(C). Results are shown as meanGS.E.M. *P!0.05, **P!0.01 and
***P!0.001 versus CTL (nZ3–7).Analysis of UPR and TRB3 expression under PA and
IL6 treatments
Representative blots of the effects of IL6 and PA treatments
on BiP, ATF4, CHOP, and TRIB3 protein contents are
shown in Fig. 5A. Both the appearance of phosphorylated
PERK (Fig. 5B) and the splicing of Xbp1 (Fig. 5C) were
stimulated by PA, in such a way that the addition of IL6 did
not interfere with this upregulation. Neither IL6 nor PA
modulated BiP content (Fig. 5D). On the other hand, ATF4www.endocrinology-journals.organd CHOP contents were increased by PA treatment (1.9-
and 2.2-fold of the CTL values respectively; Fig. 5E and F
respectively). Addition of IL6 to the medium did not
modulate PA-induced increase in ATF4 and CHOP. PA,
either alone or in combination with IL6, did not change
eIF2a phosphorylation (data not shown). We have also shown
that the expression of TRIB3 presented a pattern that was theJournal of Endocrinology (2010) 206, 183–193
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Figure 4 Modulation of BCL2 and BAX expression by palmitate and
IL6. RINm5F cells were treated with IL6 (100 ng/ml for 36 h).
Palmitate (PA; 250 mM) was added during the last 12 h of the 36-h
period, and the cells were then processed for RNA extraction and
cDNA synthesis. CTL cells were treated with a vehicle. Samples
were used for real-time PCR analysis of Bcl2 (A) and Bax (C).
Another set of cells was subjected to the same treatment, and
processed for protein extraction and western blot detection of BCL2
(B) and BAX (D). The ratio between Bcl2 and Bax mRNA (E) and
BCL2 and BAX protein content were also calculated (F). Results are
shown as meanGS.E.M. *P!0.05, **P!0.01 and ***P!0.001
versus CTL; #P!0.001 versus IL6 (nZ3–6).
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increased by PA treatment (1.8-fold of the CTL values), and
were not affected by the presence of IL6 (Fig. 5G). A profile
that was the same as that found for TRIB3 protein expression
was detected for Trib3 mRNA expression analyzed by real-
time PCR (data not shown).CTL IL6 IL6+PAPA CTL IL6 IL6+PAPA
00
Figure 5 Modulation of UPR-related proteins by PA and IL6.
RINm5F cells were treated with IL6 (100 ng/ml for 36 h). Palmitate
(PA; 250 mM) was added during the last 12 h of the 36-h period. CTL
cells were treated with a vehicle. Next, the cells were processed for
protein extraction and western blot detection of BiP, ATF4, CHOP,
TRIB3, and b-actin (A). For phosphorylated PERK detection, an
additional sample of RINm5F cells treated with thapsigargin (1 mM
for 12 h; THAP) was used as a positive CTL (B). Another set of cells
was subjected to the same treatment, and processed for RNA
extraction and cDNA synthesis. Samples were used for Xbp1
amplification followed by analysis of alternative splicing using PstI
digestion (C). The intensity of the bands of BiP (D), ATF4 (E), CHOP
(F), and TRIB3 (G) was analyzed by densitometry using different sets
of experiments. Results are shown as meanGS.E.M. *P!0.05 and
**P!0.01 versus CTL and IL6 (nZ6–9).Modulation of DNA fragmentation and ER stress by IL6 in rat
pancreatic islets cultured with PA
Our data show that both IL6 and PA increase DNA
fragmentation in pancreatic islets cultured for 24 h (to
w1.6-fold of the CTL values). The combination of PA and
IL6 resulted in a further increase in DNA fragmentation
(to 2.4-fold of the CTL values; Fig. 6A). Figure 6B shows
the representative blots of CHOP and TRIB3 obtained in
cultured pancreatic islets. PA increased both CHOP and
TRIB3 protein contents in islets to 2.4- and 3.0-fold of the
CTL values respectively. These changes were not modulated
by IL6 (Fig. 6C and D respectively).Journal of Endocrinology (2010) 206, 183–193Analysis of UPR and TRIB3 expression under CM and
IL6 treatments
Representative blots of the effects of IL6 and CM treatments
on BiP, ATF4, CHOP and TRIB3 protein contents are
shown in Fig. 7A. Neither IL6 nor CM modulated BiP
content (Fig. 7B). CM induced a 1.6-fold increase in ATF4
content, which was suppressed by the presence of IL6
(Fig. 7C). In addition, CHOP (Fig. 7D) and TRIB3 (Fig. 7E)
contents were not changed by CM and/or IL6 treatment.CHOP knockdown with siRNA suppresses PA-induced
apoptosis in RINm5F cells
As shown previously herein, PA induced an increase in DNA
fragmentation in RINm5F cells (Fig. 8B). Specific knock-
down of CHOP with siRNA (Fig. 8A) had no effect on basal
DNA fragmentation, but it abolished the ability of PA to
increase it. DNA fragmentation that was induced by PA inwww.endocrinology-journals.org
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Figure 6 Effects of palmitate and IL6 on apoptosis and UPR-related
proteins in pancreatic rat islets. Isolated rat islets were treated with
IL6 (100 ng/ml) and palmitate (PA; 1 mM) for 24 h, and processed
for the analysis of DNA fragmentation by propidium iodide
fluorescence (A) and western blotting. In (B), the representative film
image of CHOP, TRIB3, and b-actin (loading control) is shown. In
(C) and (D), the meanGS.E.M. of CHOP and TRIB3 protein contents
that were obtained from two to three independent experiments and
analyzed by densitometry is shown. *P!0.05 versus CTL; and
**P!0.01 and ***P!0.001 versus CTL and IL6 (nZ6–18 for DNA
fragmentation analysis).
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was 0.7-fold of that induced by PA in untransfected cells,
reaching values similar to the CTL values (1.1-fold).D E
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Figure 7 Modulation of UPR-related proteins by cytokines mixture
and IL6. RINm5F cells were treated with IL6 (100 ng/ml) in
combination with or without a mixture of IL1b (4.4 ng/ml), IFN-g
(10.3 ng/ml), and TNFa (4.4 ng/ml; cytokine mixture, CM). CTL
cells were treated with a vehicle. After 24 h, the cells were
processed for protein extraction and western blot detection of BiP,
ATF4, CHOP, TRIB3, and the internal control b-actin (A). The
intensity of the bands of BiP (B), ATF4 (C), CHOP (D), and TRIB3 (E)
was analyzed by densitometry using different sets of experiments.
Results are shown as meanGS.E.M. *P!0.05 versus CTL (nZ4–8).Discussion
IL6 has been suggested to protect pancreatic b-cells from
apoptosis induced by TNF-a, IFN-g, and IL-1b, which are
the main pro-inflammatory cytokines involved in the assault
of the endocrine pancreas during the onset of T1DM (Park
et al. 2003, Choi et al. 2004). Moreover, mating of mice that
overexpress IL6 with NOD mice decreased the incidence of
diabetes (DiCosmo et al. 1994). On the other hand, IL6 was
reported to decrease insulin secretion and b-cell proliferation
(Sandler et al. 1990). These observations show that the role of
IL6 in b-cell survival and function is complex, and justify
additional studies in order to clarify the intracellular
mechanisms and cellular responses elicited by this cytokine
in pancreatic b-cells. To further address this issue, we sought
to investigate if IL6 protects b-cell against lipotoxicity
induced by FFAs.
Our study has demonstrated that IL6 activates its classical
target STAT3 in RINm5F cells. AKT pathway, a non-
canonical signaling pathway of IL6 (Hsu et al. 2004), was also
activated in RINm5F cells. IL6 by itself enhanced Bcl2
expression and decreased Bax expression, probably as a result
of STAT3 activation (Kovalovich et al. 2001). Inhibition of
the mitochondrial pathway of apoptosis by adipokines haswww.endocrinology-journals.orgbeen documented already and is in agreement with our
results. Leptin, which shares intracellular signaling pathways
with IL6, increases BCL2 and decreases BAX, altering the
BCL2:BAX ratio and reducing apoptosis induced by serum
depletion in BRIN-BD11 b-cell line (Brown & Dunmore
2007). Furthermore, we observed that IL6 decreased
apoptosis induced by pro-inflammatory cytokines.
Altogether, our results confirm that IL6 protects RINm5F
cells against pro-inflammatory cytokine-induced apoptosis, as
has been published already by others (Park et al. 2003, Choi
et al. 2004). In contrast, we have shown that IL6 potentiates
the reduction of pancreatic b-cell proliferation induced by
pro-inflammatory cytokines. We currently have no data to
explain this finding. A hypothesis is that IL6 promotes the
growth arrest of RINm5F cells, as it does in other cell types
(Kamimura et al. 2003). Of note, our experiments were
carried out for a short period during which IL6 treatment was
given, which was described to decrease islet DNA content
(Sandler et al. 1990).Journal of Endocrinology (2010) 206, 183–193
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Figure 8 Effect of palmitate on DNA fragmentation after knock-
down of CHOP with siRNA. RINm5F cells were transfected with
small interfering RNA targeted at CHOP (CHOP siRNA) or with a
scrambled control siRNA (scrambled siRNA). Lipofectamine 2000
was mixed with siRNAs and used in the CTL experiment. Palmitate
(PA; 250 mM) was added during the last 12 h of the 72-h period after
the transfection; after that, the cells were processed for total protein
extraction and SDS-PAGE. Samples from CTL, scrambled siRNA,
and CHOP siRNA cells were subjected to immunodetection of
CHOP and b-actin, the latter being used to check the specificity of
CHOP siRNA (A). DNA fragmentation was analyzed by propidium
iodide fluorescence assessed using a flow cytometer (B).
***P!0.001 versus CTL and &P!0.001 versus PA (nZ7–15).
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but in opposition to that in T1DM, b-cell apoptosis in T2DM
is likely to result mainly from lipotoxicity and glucotoxicity.
PA, are of the most abundant FFAs found in serum (Hamilton
& Kamp 1999), is known as a potent inductor of b-cell
apoptosis in primary b-cells and RINm5F cells (Beeharry
et al. 2004, Azevedo-Martins et al. 2006). Our results show
that IL6 did not protect RINm5F cells from PA-induced
apoptosis. This finding is supported by clinical observations
showing that obese and insulin-resistant patients often
develop T2DM regardless of increased IL6 circulating levels
(Herder et al. 2006).
In contrast to that observed in b-cell lineage, our results
show that IL6 potentiated PA-induced apoptosis in cells
obtained from cultured islets. Ellingsgaard et al. (2008) found
similar results using cultured mouse islets. We do not have any
explanation for this, but we can speculate that the release of
cytotoxic mediators by the variety of resident cell types in
islets, that is, macrophages, endothelial cells, and endocrine
cells, could play a detrimental role in islet survival. Of note,
collagenase-isolated islets have higher apoptotic rate thanJournal of Endocrinology (2010) 206, 183–193b-cell lineages, probably due, at least in part, to the release of
pro-inflammatory cytokines induced by endotoxin contami-
nation of the conventional type V collagenase (Berney et al.
2001). Indeed, several reports have shown that IL6 alone is
not cytotoxic to b-cells (reviewed by Kristiansen &
Mandrup-Poulsen (2005)). However, phenotypic differences
between primary b-cells and clonal b-cell lines cannot be
ruled out.
The mechanism underlying the inability of IL6 to protect
RINm5F cells against PA-induced apoptosis probably relies
on the disruption of IL6 signaling pathways. We have found
that phosphorylation of both STAT3 and AKTwas activated
by IL6, but only that of AKT was impaired by PA. In
pancreatic b-cells, downregulation of STAT3 activity is
mainly involved in the modulation of insulin secretion
(Gorogawa et al. 2004, Anheˆ et al. 2007). On the other
hand, it is well documented that the phosphatidylinositol
3-kinase (PI3K)/AKT signaling is a critical pathway
regulating b-cell survival (Elghazi et al. 2007), which is
impaired by FFAs (Wrede et al. 2002, Kharroubi et al. 2004).
Downstream to AKT activation, a myriad of pro-apoptotic
proteins can be phosphorylated and inhibited, such as BCL2
family members, GSK3, and FoxO1, resulting in a relief from
apoptosis (Datta et al. 1999, Wrede et al. 2002, Martinez et al.
2008). Importantly, overexpression of a constitutively active
AKT prevented FFA-induced apoptosis (Wrede et al. 2002).
ER stress-activated UPR has been shown to occur in
pancreatic islets obtained from diabetic obese animals and
human patients with T2DM (Laybutt et al. 2007). Excess of
saturated FFAs can directly trigger ER stress and UPR-
mediated apoptosis in the pancreatic b-cell-derived lineages
MIN6 (Laybutt et al. 2007) and INS1 (Karaskov et al. 2006)
and primary rat pancreatic b-cells (Kharroubi et al. 2004).
Here, we have shown that UPR was activated in RINm5F
cells by PA after 12-h incubation (250 mM), i.e. in a shorter
period and at a lower dose than those required for MIN6 and
INS1. Therefore, RINm5F cells are likely to be more
sensitive to PA-induced ER stress, in spite of there being no
change in BiP expression and eIF2a phosphorylation. These
later effects were not unexpected, since it has been previously
demonstrated that, in INS1 cells, BiP levels are not affected by
PA (Karaskov et al. 2006, Diakogiannaki et al. 2008).
Moreover, eIF2a phosphorylation is likely to be transient,
returning to basal levels after 6–16 h of treatment. Our results
confirm that UPR is far from being an all-or-nothing
response, and that it is differentially activated according to the
cell type and the stressor.
UPR consists of three branches of signaling pathways that
initially aim to adjust the increased ER demand. Activation of
UPR is triggered by the dissociation of the chaperone BiP
from the transducer proteins PERK, ATF6, and IRE1. BiP
dissociation from PERK results in its activation that leads to
eIF2a phosphorylation and ATF4 expression. This
initial pathway inhibits general translation rate, and therefore,
decreases the flux of new synthesized proteins to the
ER (Harding & Ron 2002). Thus, disruption of thewww.endocrinology-journals.org
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pancreatic b-cells to deal with increased folding demand,
and therefore, accelerates ER stress-mediated apoptosis
(Yamaguchi et al. 2008). In spite of the protective feature of
this UPR branch, PA has been shown to stimulate the
PERK/eIF2a/ATF4 pathway prior to the induction of
pancreatic b-cell death (Kharroubi et al. 2004). Herein, we
have shown that the lack of IL6 protection against
PA-induced b-cell apoptosis correlates with the inability of
this IL to prevent PERK phosphorylation and ATF4
expression induced by PA, reinforcing the idea that UPR
might mediate lipotoxicity in RINm5F cells.
Similarly, IL6 did not modulate PA-induced increase in
Xbp1 mRNA splicing. Splicing of Xbp1 mRNA is catalyzed
by IRE1a under conditions of ER disturbance. Spliced
mRNA of Xbp1 encodes for an active transcription factor that
facilitates the expression of genes involved in the ER protein
degradation (Harding & Ron 2002). The spliced mRNA of
Xbp1 has been shown to be increased in the pancreatic islets
obtained from diabetic mice, and in the pancreatic islets
treated with PA or inflammatory cytokines (Karaskov et al.
2006, Akerfeldt et al. 2008).
We and others have demonstrated that PA increases CHOP
expression in pancreatic b-cells (Wang et al. 2005, Karaskov
et al. 2006, Laybutt et al. 2007, Martinez et al. 2008). CHOP is
regulated by ATF4, and plays an essential role in the UPR-
mediated apoptosis in pancreatic b-cells (Pirot et al. 2007) in
such a way that CHOP deletion improves pancreatic b-cell
function in diabetic rodents (Song et al. 2008). As observed for
ATF4, IL6 was not able to modulate the increase in CHOP
induced by PA. The participation of CHOP in the induction
of apoptosis is not completely understood, but one hypothesis
is that this transcription factor may suppress Bcl2 expression
(McCullough et al. 2001). In accordance with ATF4 and
CHOP results, the decrease in Bcl2 expression induced by PA
was not changed by IL6. Reinforcing the role of CHOP in
FFA-induced apoptosis, we have shown that siRNA-
mediated knockdown of CHOP abolishes PA-induced
apoptosis in RINm5F cells. This result matches the data
that have been published already by performing similar
experiments using INS-1 cells (Akerfeldt et al. 2008).
Another important mechanism by which CHOP links ER
stress to apoptosis is the induction of TRIB3 expression after
dimerization with ATF4 (Ohoka et al. 2005). Herein, we have
shown that PA increases TRIB3 content irrespective of the
presence of IL6. As TRIB3 has been described to function as
a pseudokinase that inhibits AKT (Du et al. 2003), it is likely
that PA-induced TRIB3 expression inhibits AKT-serine
phosphorylation stimulated by IL6. In accordance with our
results, both PA and high glucose concentrations can trigger
UPR-dependent apoptosis in pancreatic b-cells and con-
comitantly increase TRIB3 expression (Martinez et al. 2008,
Qian et al. 2008).
Our results further suggest that the modulation of the
BCL2:BAX ratio by PA in RINm5F cells is possibly linked to
the activation of ER stress. This can be hypothesized becausewww.endocrinology-journals.orgi) CHOP was demonstrated to downregulate BCL2
expression (McCullough et al. 2001), and ii) reduced AKT
activation might allow the transcription factor FoxO1 to
translocate to the nucleus and to induce BAX expression
(Kim et al. 2005). In the latter mechanism, ER stress can
disrupt AKT activation by inducing TRIB3 expression. In
accordance with these two mechanisms, our results show
concordant suppression of IL6-induced Bcl2 expression and
increase in CHOP by PA. We have also shown that PA
sustains high levels of Bax expression in parallel to increased
TRIB3, and decreases AKT activity.
Akerfeldt et al. have demonstrated that although pro-
inflammatory ILs are able to induce ER stress and activate
UPR, this mechanism is not required for the pro-apoptotic
action of these cytokines. On the other hand, these authors
suggested that the activation of UPR is a determinant event
that culminates in the apoptosis induced by PA (Akerfeldt
et al. 2008). Considering these observations, our data suggest
that IL6 does not prevent or abolish the disturbance in ER
homeostasis elicited by PA, and thus it is not able to protect
pancreatic b-cells from apoptosis induced by elevated FFAs.
In contrast, as we and others have demonstrated, IL6 can
properly protect b-cells against pro-inflammatory-induced
apoptosis probably because in this case it has been
consistently demonstrated that ER stress does not mediate
cell death.
Corroborating this hypothesis, we have shown that the
combination of pro-inflammatory cytokines used by us
efficiently increases DNA fragmentation and caspase-3
activity without increasing BiP, TRIB3, and CHOP, which
are proteins that link ER stress to apoptosis in pancreatic
b-cells. In contrast, Akerfeldt et al. (2008) reported that
inflammatory cytokines are able to increase CHOP and BiP
expression. One plausible explanation for these differences is
that the mixture of inflammatory cytokines used by Akerfeldt
contained IFN-g at a concentration that was ten times that of
IFN-g that was used by us. In our experimental conditions,
the only UPR-related protein that paralleled the increase in
apoptosis induced by CM in RINm5F cells was ATF4, which
was suppressed by IL6. The exact role of this modulation is
not clear so far, since the PERK/eIF2a/ATF4 pathway seems
to be protective rather than pro-apoptotic to pancreatic
b-cells (Yamaguchi et al. 2008).
Taken together, our results show that differently from the
pro-inflammatory cytokines that trigger apoptosis, IL6 does
not prevent PA-induced b-cell death. This effect is probably
due to the inability of IL6 to repress UPR activation and
TRIB3 expression, which may result in the blockage of
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